Analysis of cardiovascular and cardiometabolic risks in the association of bronchial asthma and obesity
D.A. ANIKIN, I.A. SOLOVYEVA, I.V. DEMKO, E.A. SOBKO, N.V. GORDEEVA, A.YU. KRAPOSHINA
Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk
Krasnoyarsk Clinical Regional Hospital, Krasnoyarsk
Contact details:
Anikin D.A. — Assistant Lecturer of the Department of Hospital Therapy and Immunology and Postgraduate Physician Training Course; pulmonologist
Address: 2К Aerovokzalnaya St., Krasnoyarsk, Russian Federation, 660022, tel.: +7-983-140-27-37, e-mail: anikin27111994@mail.ru
Bronchial asthma and obesity are showing a steady increase in incidence worldwide, incurring significant economic losses for society. There is no doubt about the pathogenetic role of obesity in the development of cardiovascular events.
The purpose is to analyze the current data that demonstrate the impact of asthma and obesity association on the increased risk of cardiovascular disease. The critical role of obesity is noted as a risk factor for the development and progression of both bronchial asthma and cardiovascular diseases. The review emphasizes importance of determining cardiovascular and cardiometabolic risks according to generally accepted scales specified in clinical guidelines. As part of the review, the combination of bronchial asthma and cardiovascular diseases was analyzed, and their etiopathogenetic interdependence was noted. The role of metabolic processes in adipose tissue is shown, which can increase both inflammation in bronchial asthma and lead to the progression of cardiovascular diseases. Understanding the mechanisms of mutual influence will allow for personalized treatment, as well as the prevention of cardiovascular accidents in patients with bronchial asthma and obesity.
Key words: bronchial asthma, obesity, metabolic syndrome, cardiovascular risks, cardiometabolic risks.
REFERENCES
- Avdeev S.N., Nenasheva N.M., Zhudenkov K.V. Prevalence, incidence, phenotypes and other characteristics of severe bronchial asthma in the Russian Federation. Pul’monologiya, 2018, vol. 28, no. 3, pp. 341–358 (in Russ.). DOI: 10.18093/0869-0189-2018-28-3-341-358
- Kim D., Basu A. Estimating the Medical Care Costs of Obesity in the United States: Systematic Review, Meta-Analysis, and Empirical Analysis. Value Health, 2016, no. 19, pp. 602–613. DOI: 10.1016/j.jval.2016.02.008
- Verbovoy A.F., Pashentseva A.V., Sharonova L.A. Obesity and the cardiovascular system. Klinicheskaya meditsina, 2017, vol. 95, no. 1, pp. 31–35 (in Russ.). DOI: 10.18821/0023-2149-2017-95-1-31-35
- Strand L.B., Tsai M.K., Wen C.P., Chang S.S., Brumpton B.M. Is having asthma associated with an increased risk of dying from cardiovascular disease? A prospective cohort study of 446 346 Taiwanese adults. BMJ Open, 2018, vol. 8 (5), p. e019992. DOI:10.1136/bmjopen-2017-019992
- Markova T.N., Fomina D.S., Kostenko A.A., Bobrikova E.N. Obesity and bronchial asthma: two diseases with common aspects of pathogenesis. Profilakticheskaya meditsina, 2020, vol. 23, no. 4, pp. 126–132. DOI:10.17116/profmed202023041126
- Liu H., Fu Y., Wang K. Asthma and risk of coronary heart disease: A meta-analysis of cohort studies. Ann Allergy Asthma Immunol, 2017, vol. 118 (6), pp. 689–695. DOI: 10.1016/j.anai.2017.03.012
- Wee J.H., Park M.W., Min C. Association between asthma and cardiovascular disease. Eur J Clin Invest, 2021, vol. 51 (3), p. e13396. DOI: 10.1111/eci.13396
- Uryas’ev O.M. Bronchial asthma and comorbid cardiac pathology: frequency and clinical and functional features. Zemskiy vrach, 2012, vol. 20, no. 3, pp. 22–27 (in Russ.).
- Seidell J.C., de Groot L.C., van Sonsbeek J.L., Deurenberg P., Hautvast J.G. Associations of moderate and severe overweight with self-reported illness and medical care in Dutch adults. Am J Public Health, 1986, vol. 76, pp. 264–269. DOI: 10.2105/ajph.76.3.264
- Dwivedi A.K., Dubey P., Cistola D.P., Reddy S.Y. Association Between Obesity and Cardiovascular Outcomes: Updated Evidence from Meta-analysis Studies. Curr Cardiol Rep, 2020, vol. 22 (4), p. 25. DOI: 10.1007/s11886-020-1273-y
- Zhao S., Cao R., Zhang S., Kang Y. Explore the Protective Role of Obesity in the Progression of Myocardial Infarction. Front Cardiovasc Med, 2021, no. 8, 629734. DOI: 10.3389/fcvm.2021.629734
- Leite N.N., Cota B.C., Gotine A., Rocha D., Pereira P.F., Hermsdorff H.H.M. Visceral adiposity index is positively associated with blood pressure: A systematic review. Obes Res Clin Pract, 2021, vol. 15 (6), pp. 546–556. DOI: 10.1016/j.orcp.2021.10.001
- Lind L., Strand R., Kullberg J., Ahlström H. Cardiovascular-related proteins and the abdominal visceral to subcutaneous adipose tissue ratio. Nutr Metab Cardiovasc Dis, 2021, vol. 31 (2), pp. 532–539. DOI: 10.1016/j.numecd.2020.09.010
- Rastogi D., Fraser S., Oh J., Huber A.M., Schulman Y., Bhagtani R.H., Khan Z.S., Tesfa L., Hall C.B., Macian F. Inflammation, metabolic dysregulation, and pulmonary function among obese urban adolescents with asthma. Am J Respir Crit Care Med, 2015, vol. 191 (2), pp. 149–160. DOI: 10.1164/rccm.201409-1587OC
- Allinson J.P., Patel P.H., Donaldson G.C. Obesity, Insulin Resistance, and Asthma. Am J Respir Crit Care Med, 2022, vol. 206 (9), rr. 1057–1058. DOI: 10.1164/rccm.202207-1271ED
- Zhang P., Lopez R., Attaway A.H., Georas S.N., Khatri S.B., Abi-Saleh S., Zein J.G. Diabetes Mellitus Is Associated with Worse Outcome in Patients Hospitalized for Asthma. J Allergy Clin Immunol Pract, 2021, vol. 9 (4), rr. 1562–1569. DOI: 10.1016/j.jaip.2020.10.054
- Serafi A.S. Adipocytokinesin blood pressure variations and hypertension: An overview. Int J Biol Biotech, 2018, no. 15, rr. 1–12.
- Ferland D.J., Mullick A.E., Watts S.W. Chemerin as a Driver of Hypertension: A Consideration. Am J Hypertens, 2020, vol. 33 (11), rr. 975–986. DOI: 10.1093/ajh/hpaa084
- Papi A., Brightling C., Pedersen S.E., Reddel H.K. Asthma. The Lancet, 2018, vol. 391 (10122), rr. 783–800. DOI: 10.1016/s0140-6736(17)33311-1
- Wang L., Gao S., Yu M., Sheng Z., Tan W. Association of asthma with coronary heart disease: A metaanalysis of 11 trials. PLoS One, 2017, vol. 12 (6), rr. e0179335. DOI: 10.1371/journal.pone.0179335
- Cepelis A., Brumpton B.M., Laugsand L.E., Dalen H., Langhammer A., Janszky I., Strand L.B. Asthma, asthma control and risk of acute myocardial infarction: HUNT study. Eur J Epidemiol, 2019, vol. 34 (10), rr. 967–977. DOI: 10.1007/s10654-019-00562-x
- Bang D.W., Wi C.I., Kim E.N., Hagan J. et al. Asthma Status and Risk of Incident Myocardial Infarction: A Population-Based Case-Control Study. The journal of allergy and clinical immunology In practice, 2016, vol. 4 (5), rr. 917–923. DOI: 10.1016/j.jaip.2016.02.018
- Niccoli G., Montone R.A., Sabato V., Crea F. Role of Allergic Inflammatory Cells in Coronary Artery Disease. Circulation, 2018, vol. 138 (16), rr. 1736–1748. DOI: 10.1161/CIRCULATIONAHA.118.035400
- Belyalov F.I. Lechenie bolezney v usloviyakh komorbidnosti [Treatment of diseases in conditions of comorbidity]. Moscow: Geotar-media, 2016. 544 p.
- Nelson H.S., Weiss S.T., Bleecker E.R., Yancey S.W., Dorinsky P.M. The Salmeterol Multicenter Asthma Research Trial. A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest, 2006, vol. 129 (15), rr. 15–26. DOI: 10.1378/chest.129.1.15
- Sorbets E., Steg P.G., Young R., Danchin N. et al. β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study. Eur Heart J, 2019, vol. 40 (18), rr. 1399–1407. DOI: 10.1093/eurheartj/ehy811
- Luss L.V., Belousov Yu.B., Sidorovich O.I., Glushkova E.F. New opportunities in the treatment of bronchial asthma. Effective pharmacotherapy. Pul’monologiya i otorinolaringologiya, 2017, vol. 3, no. 1, pp. 10–16 (in Russ.).
- Garmazina M.V., Budnevskiy A.V. Bronchial asthma and hypertension: features of the clinical and psychological status and rehabilitation of patients with comorbidities. Nauchno-med. vestn. tsentral’nogo Chernozem’ya, 2008, no. 32, pp. 63–69 (in Russ.).
- Bhaskaran K., Dos-Santos-Silva I., Leon D.A., Douglas I.J., Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol, 2018, vol. 6 (12), rr. 944–953. DOI: 10.1016/S2213-8587(18)30288-2
- Ushakov V.F. Study of the relationship between inflammation markers and blood pressure in patients with bronchial asthma with pulmogenic arterial hypertension. Med. nauka i obrazovanie Urala, 2010, vol. 4, no. 11, pp. 87–89 (in Russ.).
- Cazzola M., Noschese P., D’Amato G., Matera M.G. The pharmacologic treatment of uncomplicated arterial hypertension in patients with airway dysfunction. Chest, 2002, vol. 121 (1), rr. 230–241.
- Christiansen S.C., Zuraw B.L. Treatment of hypertension in patients with asthma. The New England Journal of Medicine, 2019, vol. 381 (11), rr. 1046–1057. DOI: 10.24412/2076-4189-2022-12700
- Chang Y.L., Ko H.K., Lu M.S., Chou C.L. et al. Independent risk factors for death in patients admitted for asthma exacerbation in Taiwan. NPJ Prim Care Respir Med, 2020, vol. 30 (1), rr. 7. DOI: 10.1038/s41533-020-0164-4
- Rørth R., Fosbøl E.L., Mogensen U.M., Iversen K. et al. The importance of β2-agonists in myocardial infarction: Findings from the Eastern Danish Heart Registry. Eur Heart J Acute Cardiovasc Care, 2016, vol. 5 (8), rr. 551–559. DOI: 10.1177/2048872615606599
- Hsu C.Y., Lehman H.K., Wood B.L. et al. Comorbid Obesity and Depressive Symptoms in Childhood Asthma: A Harmful Synergy. J Allergy Clin Immunol Pract, 2020, vol. 8 (8), rr. 2689–2697. DOI: 10.1016/j.jaip.2020.03.036